Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Kelly

Showing results (201-210 of 253) with videos related to

Pageof 26
Sort By:
American Journal of Cancer Therapy and Pharmacology|January 13, 2015
A pilot phase II Study of digoxin in patients with recurrent prostate cancer as evident by a rising PSAJianqing Lin, Tingting Zhan, Danielle Duffy, et al.
Journal of Racial and Ethnic Health Disparities|June 18, 2025
Health Status And Delays In Referral-To-Treatment Waiting Times for Elective Admissions of Adults From Deprived Areas And Ethnic Minority Backgrounds: A Study of Healthcare InequalitiesDavid Fluck, Emma Jackson, Ana Llamas-Montoya, et al.
The Journal of Urology|July 24, 2007
Innovations and challenges in prostate cancer: summary statement for the 6th Cambridge ConferencePhilip W Kantoff, Tomasz M Beer, Anthony V D'Amico, et al.
Blood|July 24, 2010
Heat shock protein 90 regulates the expression of Wilms tumor 1 protein in myeloid leukemiasHima Bansal, Sanjay Bansal, Manjeet Rao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2015
Phase I Study of the Novel Investigational NEDD8-Activating Enzyme Inhibitor Pevonedistat (MLN4924) in Patients with Relapsed/Refractory Multiple Myeloma or LymphomaJatin J Shah, Andrzej J Jakubowiak, Owen A O'Connor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 18, 2005
Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancerWilliam Kevin Kelly, Owen A O'Connor, Lee M Krug, et al.
Prostate Cancer and Prostatic Diseases|February 23, 2022
Substantial Gleason reclassification in Black men with national comprehensive cancer network low-risk prostate cancer - A propensity score analysisShivanshu Awasthi, Brandon A Mahal, Jong Y Park, et al.
BMC Pregnancy and Childbirth|May 16, 2021
Reduction in massive postpartum haemorrhage and red blood cell transfusion during a national quality improvement project, Obstetric Bleeding Strategy for Wales, OBS Cymru: an observational studySarah F Bell, Rachel E Collis, Philip Pallmann, et al.
The Canadian Journal of Urology|June 21, 2023
Enhancing bladder cancer care through the multidisciplinary clinic approachJ Ryan Mark, Leonard G Gomella, Costas D Lallas, et al.
International Journal of Radiation Oncology, Biology, Physics|July 19, 2014
Genomic prostate cancer classifier predicts biochemical failure and metastases in patients after postoperative radiation therapyRobert B Den, Felix Y Feng, Timothy N Showalter, et al.
Pageof 26

Showing results (201-210 of 253) with videos related to

Sort By:
Pageof 26
American Journal of Cancer Therapy and Pharmacology|January 13, 2015
A pilot phase II Study of digoxin in patients with recurrent prostate cancer as evident by a rising PSAJianqing Lin, Tingting Zhan, Danielle Duffy, et al.
Journal of Racial and Ethnic Health Disparities|June 18, 2025
Health Status And Delays In Referral-To-Treatment Waiting Times for Elective Admissions of Adults From Deprived Areas And Ethnic Minority Backgrounds: A Study of Healthcare InequalitiesDavid Fluck, Emma Jackson, Ana Llamas-Montoya, et al.
The Journal of Urology|July 24, 2007
Innovations and challenges in prostate cancer: summary statement for the 6th Cambridge ConferencePhilip W Kantoff, Tomasz M Beer, Anthony V D'Amico, et al.
Blood|July 24, 2010
Heat shock protein 90 regulates the expression of Wilms tumor 1 protein in myeloid leukemiasHima Bansal, Sanjay Bansal, Manjeet Rao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2015
Phase I Study of the Novel Investigational NEDD8-Activating Enzyme Inhibitor Pevonedistat (MLN4924) in Patients with Relapsed/Refractory Multiple Myeloma or LymphomaJatin J Shah, Andrzej J Jakubowiak, Owen A O'Connor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 18, 2005
Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancerWilliam Kevin Kelly, Owen A O'Connor, Lee M Krug, et al.
Prostate Cancer and Prostatic Diseases|February 23, 2022
Substantial Gleason reclassification in Black men with national comprehensive cancer network low-risk prostate cancer - A propensity score analysisShivanshu Awasthi, Brandon A Mahal, Jong Y Park, et al.
BMC Pregnancy and Childbirth|May 16, 2021
Reduction in massive postpartum haemorrhage and red blood cell transfusion during a national quality improvement project, Obstetric Bleeding Strategy for Wales, OBS Cymru: an observational studySarah F Bell, Rachel E Collis, Philip Pallmann, et al.
The Canadian Journal of Urology|June 21, 2023
Enhancing bladder cancer care through the multidisciplinary clinic approachJ Ryan Mark, Leonard G Gomella, Costas D Lallas, et al.
International Journal of Radiation Oncology, Biology, Physics|July 19, 2014
Genomic prostate cancer classifier predicts biochemical failure and metastases in patients after postoperative radiation therapyRobert B Den, Felix Y Feng, Timothy N Showalter, et al.
Pageof 26